Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactionsJohn Paul Shen, Prashant Mali, Dongxin Zhao et al.|Nature Methods|2017Cited by 372
Survival improvement for patients with metastatic colorectal cancer over twenty yearsFadl A. Zeineddine, John Paul Shen, Bryan K. Kee et al.|npj Precision Oncology|2023Cited by 172
Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i><sup>V600E</sup> metastatic colorectal cancer.Van K. Morris, Scott Kopetz, Christine M. Parseghian et al.|Journal of Clinical Oncology|2022Cited by 78
Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 StudyLisa Licitra, Robert I. Haddad, Makoto Tahara et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 32